Literature DB >> 5079897

The nature of the reverse type I (modified type II) spectral change in liver microsomes.

J B Schenkman, D L Cinti, S Orrenius, P Moldeus, R Kraschnitz.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5079897     DOI: 10.1021/bi00773a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  11 in total

Review 1.  CYP17 inhibitors for prostate cancer therapy.

Authors:  Tadas S Vasaitis; Robert D Bruno; Vincent C O Njar
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-17       Impact factor: 4.292

Review 2.  Fatty acid hydroxylation in rat kidney cortex microsomes.

Authors:  A Ellin; S Orrenius
Journal:  Mol Cell Biochem       Date:  1975-08-30       Impact factor: 3.396

3.  Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study.

Authors:  Tsutomu Shimada; Katsuhiro Tanaka; Shigeo Takenaka; Maryam K Foroozesh; Norie Murayama; Hiroshi Yamazaki; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

4.  Drug modulation of water-heme interactions in low-spin P450 complexes of CYP2C9d and CYP125A1.

Authors:  Kip P Conner; Alex A Cruce; Matthew D Krzyaniak; Alina M Schimpf; Daniel J Frank; Paul Ortiz de Montellano; William M Atkins; Michael K Bowman
Journal:  Biochemistry       Date:  2015-01-29       Impact factor: 3.162

5.  CW EPR parameters reveal cytochrome P450 ligand binding modes.

Authors:  Molly M Lockart; Carlo A Rodriguez; William M Atkins; Michael K Bowman
Journal:  J Inorg Biochem       Date:  2018-02-24       Impact factor: 4.155

6.  Inhibition of cytochrome P-450-dependent mixed function oxidation by ethanol.

Authors:  N Hayashi; T Kamada; N Sato; A Kasahara; J A Peterson
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

7.  Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1.

Authors:  Hugues Ouellet; Petrea M Kells; Paul R Ortiz de Montellano; Larissa M Podust
Journal:  Bioorg Med Chem Lett       Date:  2010-11-05       Impact factor: 2.823

8.  The metabolism and binding of catecholamines by the hepatic microsomal mixed-function oxidase of the rat.

Authors:  D McKillop; G Powis
Journal:  Biochem J       Date:  1976-07-15       Impact factor: 3.857

9.  Drug metabolism in rats with arthritis induced by 6-sulfanilamidoindazole (6-SAI).

Authors:  D Müller; R Hirschelmann
Journal:  Agents Actions       Date:  1981-12

10.  Cholesterol Analogs with Degradation-resistant Alkyl Side Chains Are Effective Mycobacterium tuberculosis Growth Inhibitors.

Authors:  Daniel J Frank; Yan Zhao; Siew Hoon Wong; Debashree Basudhar; James J De Voss; Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2016-02-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.